These general survival rates are based on those who receive an initial lung cancer diagnosis at stage 4. This doesn’t apply to lung cancer that has returned. While no one can know the exact answers about your life expectancy, we do know stage 4 lung cancer patients are living longer now ...
Hi, there. I think that almost 40% of lung cancer patients are diagnosed at advanced stage. It is stage 4 that I am talking about. Other factors have influence on the life expectancy. Women tend to live longer than men. Younger people also have better prognosis. Side effects of the trea...
It is in this context that we undertook this review of cases of humeral metastasis of lung cancer (HMLC) origin.Ampil FBaluna RJournal of palliative medicineF. Ampil and R. Baluna, "Humeral metastasis in patients with stage IV non-small-cell lung cancer portends a short life expectancy,"...
4 Yale Stem Cell Center, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520, USA. 5 Yale Cancer Center, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520, USA. 6 Department of Cell Biology, Yale University School of Medicine, ...
Health and Quality of Life Outcomes (2018) 16:179 https://doi.org/10.1186/s12955-018-0994-8 REVIEW Open Access Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients Noman Paracha1*, Ahmed Abdulla1,3 and ...
Targeting VM might bring a new breakthrough in cancer treatment. Thrombin is the key enzyme of the blood coagulation system and could contribute to tumor progression. Nevertheless, the association between thrombin and VM formation remains largely unknown. We found that VM was associated with the ...
Danjuma KJ (2015) Performance evaluation of machine learning algorithms in post-operative life expectancy in the lung cancer patients. Int J Comput Sci Issues 12:1-11KwetisheJoro Danjuma. (2015), "Performance evaluation of machine learn- ing algorithms in post-operative life expectancy in the ...
This narrative review deepens the current evidence about efficacy and toxicity of ICBs in older patients with advanced stage non-small cell lung cancer (NSCLC), the role of geriatric tests in supporting the selection of patients for immunotherapy, as well as the value of circulating biomarkers, in...
3, Dong Ding1, Shuosha Li1, Mengting Liao4, Yin Shi5 and Jin Huang1,6* Abstract Background: The clinical trial of Keynote-604 showed that pembrolizumab plus chemotherapy could generate clini- cal benefits for extensive-stage small-cell lung cancer (ES-SCLC)...
In the staging of mediastinal lymph nodes before lung cancer surgery, endobronchial ultrasound transbronchial needle aspirations (EBUS-TBNA) has proven to be highly sensitive and specific as well as safe. • Although positron emission tomography/computed tomography (PET/CT) has been a major developme...